Greenwich LifeSciences, Inc. (GLSI) stock
GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.94−0.34 (-2.23%)
Close on Nov 13, 2026Market cap $219.29MP/E –Yield –
Greenwich LifeSciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Greenwich LifeSciences
Greenwich LifeSciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?